Skip to main content
Kruti Joshi on Muck Rack

Kruti Joshi

Sydney
As seen in: Wiley Online Library, Taylor & Francis Online, Sky News Australia, American Journal of Managed Care, The Journal of Clinical Psychiatry, Future Medicine, Mediaweek (Australia)
Multimedia storytelling enthusiast, @SkyNewsAust Audio Producer, ex-@MediaweekAUS, name appeared on CNN *faint* ||Tweets & views are my own||
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kruti

Contact Kruti, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Nuclear Media acquires kids mags K-Zone and Total Girl

|
By Mediaweek Freelancer, James Manning Verified, Kruti Joshi
| Mediaweek (Australia) Verified
K-Zone and Total Girl have been acquired by Nuclear Media, the specialist publisher focused on youth and entertainment content, from nextmedia. The children’s magazine brands have been staples have shaped pop culture, fuelled imaginations, and inspired generations of young readers for more than two decades. The acquisition marks an important milestone for Nuclear Media as it expands its portfolio in the youth market.
Open in Who Shared Issue with article?

Assessment of patient-reported depression severity in subpopulation of ESCAPE-TRD study: esketamine nasal spray versus quetiapine extended release for treatment-resistant depression

|
By Kristin Clemens, Kruti Joshi, Benoit Rive, Pushpike Thilakarathne
| Taylor & Francis Online
Abstract Objective ESCAPE-TRD, a randomized phase 3b trial, compares the efficacy and safety of esketamine nasal spray (NS) and extended-release (XR) quetiapine, both in combination with ongoing oral antidepressant (OAD) treatment, among individuals with treatment-resistant depression (TRD). Although prior analyses used the clinician-rated MADRS, the comparative efficacy of esketamine NS vs.
Open in Who Shared Issue with article?

Barriers to Esketamine Nasal Spray Treatment Among Adults With Treatment-Resistant Depression

|
By Kruti Joshi, Purva Parab, Jonathan D. Darer, Joshua N. Liberman
| The Journal of Clinical Psychiatry Verified
Abstract Background: Under a risk evaluation and mitigation strategy program, esketamine nasal spray CIII requires self administration at a certified treatment center. Our objective was to identify factors associated with esketamine initiation and continuation. Methods: A retrospective observational cohort study was conducted among US adults who met treatment-resistant depression (TRD) criteria.
Open in Who Shared Issue with article?
See all 363 licensed articles (364 Total)